feed,title,long_url,short_url
gNews,A biotech stock just rocketed 608% after announcing positive phase 3 trial data (MCRB) - Business Insider,https://www.businessinsider.com/seres-therapeutics-stock-price-positive-phase-3-trial-data-biotech-2020-8,https://j.mp/3kAoSNd
